These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 8157136)
21. Cytostatic effect of 9-(2-phosphonomethoxyethyl) adenine (PMEA). I. Lymphatic leukemia KHP-Lw-I in Lewis rats. Otová B; Sladká M; Votruba I; Holý A; Kren V Folia Biol (Praha); 1993; 39(3):136-41. PubMed ID: 8157134 [TBL] [Abstract][Full Text] [Related]
22. In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir? Andrei G; De Clercq E; Snoeck R Antiviral Res; 2004 Mar; 61(3):181-7. PubMed ID: 15168799 [TBL] [Abstract][Full Text] [Related]
23. Effects of phosphonylmethoxyalkyl-purine and -pyrimidine derivatives on TK+ and TK- HSV-1 keratitis in rabbits. Maudgal PC; De Clercq E Antiviral Res; 1991 Jul; 16(1):93-100. PubMed ID: 1663731 [TBL] [Abstract][Full Text] [Related]
24. Selection and characterisation of murine leukaemia L1210 cells with high-level resistance to the cytostatic activity of the acyclic nucleoside phosphonate 9-(2-phosphonylmethoxyethyl) adenine (PMEA). Balzarini J; Hatse S; Naesens L; De Clercq E Biochim Biophys Acta; 1998 Mar; 1402(1):29-38. PubMed ID: 9551083 [TBL] [Abstract][Full Text] [Related]
25. Chemokines, nitric oxide and antiarthritic effects of 9-(2-phosphonomethoxyethyl)adenine (Adefovir). Zídek Z; Franková D; Holý A Eur J Pharmacol; 1999 Jul; 376(1-2):91-100. PubMed ID: 10440094 [TBL] [Abstract][Full Text] [Related]
26. Pretreatment of the host cell with 1-(S)-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) is sufficient for its antiviral effect. Otová B; Votruba I; Holý A Acta Virol; 1992 May; 36(3):313-9. PubMed ID: 1360759 [TBL] [Abstract][Full Text] [Related]
27. Therapeutic potential of phosphonylmethoxyalkylpurines and -pyrimidines as antiviral agents. De Clercq E Drugs Exp Clin Res; 1990; 16(7):319-26. PubMed ID: 1965499 [TBL] [Abstract][Full Text] [Related]
28. Activities of acyclic nucleoside phosphonates against Orf virus in human and ovine cell monolayers and organotypic ovine raft cultures. Dal Pozzo F; Andrei G; Holy A; Van Den Oord J; Scagliarini A; De Clercq E; Snoeck R Antimicrob Agents Chemother; 2005 Dec; 49(12):4843-52. PubMed ID: 16304144 [TBL] [Abstract][Full Text] [Related]
29. Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine. Ho HT; Woods KL; Bronson JJ; De Boeck H; Martin JC; Hitchcock MJ Mol Pharmacol; 1992 Jan; 41(1):197-202. PubMed ID: 1310143 [TBL] [Abstract][Full Text] [Related]
30. Phosphorylation of 9-(2-phosphonomethoxyethyl)adenine and 9-(S)-(3-hydroxy-2-phosphonomethoxypropyl)adenine by AMP(dAMP) kinase from L1210 cells. Merta A; Votruba I; Jindrich J; Holý A; Cihlár T; Rosenberg I; Otmar M; Herve TY Biochem Pharmacol; 1992 Nov; 44(10):2067-77. PubMed ID: 1449524 [TBL] [Abstract][Full Text] [Related]
31. Comparative effect of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine treatment on cytomegalovirus-induced interstitial pneumonitis in allogeneic bone marrow transplant recipient rats. Stals FS; Zeytinoglu A; Havennith M; de Clercq E; Bruggeman CA Transplant Proc; 1993 Feb; 25(1 Pt 2):1248-9. PubMed ID: 8382855 [No Abstract] [Full Text] [Related]
32. Transport of 9-(2-phosphonomethoxyethyl)adenine across plasma membrane of HeLa S3 cells is protein mediated. Cihlár T; Rosenberg I; Votruba I; Holý A Antimicrob Agents Chemother; 1995 Jan; 39(1):117-24. PubMed ID: 7695292 [TBL] [Abstract][Full Text] [Related]
33. Cytostatic effect of 9-(2-phosphonomethoxyethyl) adenine (PMEA). II. Lymphoblastic leukemia in Sprague-Dawley rats. Otová B; Sladká M; Blazek K; Schramlová J; Votruba I; Holý A Folia Biol (Praha); 1993; 39(3):142-9. PubMed ID: 8157135 [TBL] [Abstract][Full Text] [Related]
34. Topical HPMPC inhibits adenovirus type 5 in the New Zealand rabbit ocular replication model. Gordon YJ; Romanowski EG; Araullo-Cruz T Invest Ophthalmol Vis Sci; 1994 Nov; 35(12):4135-43. PubMed ID: 7960596 [TBL] [Abstract][Full Text] [Related]
35. Design, synthesis and evaluation of novel oxazaphosphorine prodrugs of 9-(2-phosphonomethoxyethyl)adenine (PMEA, adefovir) as potent HBV inhibitors. Lu P; Liu J; Wang Y; Chen X; Yang Y; Ji R Bioorg Med Chem Lett; 2009 Dec; 19(24):6918-21. PubMed ID: 19889538 [TBL] [Abstract][Full Text] [Related]
36. A human T lymphoid cell variant resistant to the acyclic nucleoside phosphonate 9-(2-phosphonylmethoxyethyl)adenine shows a unique combination of a phosphorylation defect and increased efflux of the agent. Robbins BL; Connelly MC; Marshall DR; Srinivas RV; Fridland A Mol Pharmacol; 1995 Feb; 47(2):391-7. PubMed ID: 7870049 [TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics, bioavailability, metabolism, and tissue distribution of cidofovir (HPMPC) and cyclic HPMPC in rats. Cundy KC; Bidgood AM; Lynch G; Shaw JP; Griffin L; Lee WA Drug Metab Dispos; 1996 Jul; 24(7):745-52. PubMed ID: 8818571 [TBL] [Abstract][Full Text] [Related]
38. Prevention of acute graft-versus-host disease in rats using 9-(2-phosphonomethoxyethyl) adenine (PMEA). Kren V; Otová B; Elleder D; Elleder M; Panczak A; Holý A Folia Biol (Praha); 1993; 39(2):78-86. PubMed ID: 8258370 [TBL] [Abstract][Full Text] [Related]
39. Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections. De Clercq E Verh K Acad Geneeskd Belg; 1996; 58(1):19-47; discussion 47-9. PubMed ID: 8701600 [TBL] [Abstract][Full Text] [Related]
40. Phosphorylation of acyclic nucleotide analogs HPMPA and PMEA in L1210 mouse leukemia cell extracts. Merta A; Veselý J; Votruba I; Rosenberg I; Holý A Neoplasma; 1990; 37(2):111-20. PubMed ID: 2160620 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]